BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4807858)

  • 1. Evaluation of leucocyte functions six years after tumour autograft in human mammary cancer.
    Anderson JM; Kelly F; Wood SE; Rodger KD; Freshney RI
    Br J Cancer Suppl; 1973 Aug; 1():83-96. PubMed ID: 4807858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Six-year study of autografts of irradiated tumour adjuvant to mastectomy and radiotherapy for cancer of the breast.
    Anderson JM
    Panminerva Med; 1975; 17(5-6):179-81. PubMed ID: 1161315
    [No Abstract]   [Full Text] [Related]  

  • 3. Stimulatory immunotherapy in mammary cancer.
    Anderson JM; Kelly F; Wood SE; Halnan KE
    Br J Surg; 1974 Oct; 61(10):778-84. PubMed ID: 4137944
    [No Abstract]   [Full Text] [Related]  

  • 4. Tumour-directed leucocyte migration inhibition in operable breast cancer: additional clinical correlations.
    Jones BM; Connolly CE; Isaacson P; Turner DT; Turnbull AR
    Br J Cancer; 1976 Jul; 34(1):94-6. PubMed ID: 952719
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of surgery on tumour-directed leucocyte responses.
    Vose BM; Moudgil GC
    Br Med J; 1975 Jan; 1(5949):56-8. PubMed ID: 1109658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Six-year study of autografts of irradiated tumour adjuvant to mastectomy and radiotherapy for cancer of the breast.
    Anderson JM
    Panminerva Med; 1973; 15(11-12):432-4. PubMed ID: 4806257
    [No Abstract]   [Full Text] [Related]  

  • 7. The immune reaction to human breast cancer: a comparison of skin and leucocyte migration tests.
    Roberts MM; Bathgate EM
    Br J Surg; 1975 Oct; 62(10):820-2. PubMed ID: 1191943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Letter: Lymphocyte response after radiotherapy.
    Wood SE; Campbell JB; Anderson JM; Kelly F
    Lancet; 1974 May; 1(7862):863. PubMed ID: 4132808
    [No Abstract]   [Full Text] [Related]  

  • 9. Proceedings: effect of surgery under anaesthesia on tumour-directed leucocyte responses.
    Moudgil GC; Vose BM
    Br J Anaesth; 1975 May; 47(5):631-2. PubMed ID: 1138783
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of migration of human autogenous and allogeneic leukocytes by extracts of patients' cancers.
    Wolberg WH
    Cancer Res; 1971 Jun; 31(6):798-802. PubMed ID: 4326036
    [No Abstract]   [Full Text] [Related]  

  • 11. Mechanisms of leucocyte migration inhibition by breast tumour cell fractions.
    Jones BM
    Br J Cancer; 1976 Jul; 34(1):14-9. PubMed ID: 952712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An examination of the immunology of cancer patients.
    Cochran AJ; Mackie RM; Grant RM; Ross CE; Connell MD; Sandilands G; Whaley K; Hoyle DE; Jackson AM
    Int J Cancer; 1976 Sep; 18(3):298-309. PubMed ID: 783052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunotherapy].
    Lejeune FJ; Bernheim JL; Vanwijck R
    Acta Chir Belg; 1974 Mar; 73(2):265-93. PubMed ID: 4450923
    [No Abstract]   [Full Text] [Related]  

  • 14. Failure to demonstrate tumour-specific leucocyte migration inhibition in vitro by cryostat sections of breast cancer tissue.
    Petrini B; Bergstrand A; Wasserman J; Blomstedt B; Blomgren H; Baral E
    Clin Oncol; 1977 Sep; 3(3):259-66. PubMed ID: 912961
    [No Abstract]   [Full Text] [Related]  

  • 15. Immune cytolysis of human tumor cells mediated by xenogeneic "immune" RNA: implications for immunotherapy.
    Pilch YH; Veltman LL; Kern DH
    Surgery; 1974 Jul; 76(1):23-34. PubMed ID: 4841349
    [No Abstract]   [Full Text] [Related]  

  • 16. Rosette-forming cells, immunologic deficiency diseases and transfer factor.
    Wybran J; Levin AS; Spitler LE; Fudenberg HH
    N Engl J Med; 1973 Apr; 288(14):710-3. PubMed ID: 4540063
    [No Abstract]   [Full Text] [Related]  

  • 17. Prolonged survival after immunotherapy (irradiated cancer autografts) or mammary cancers, assessed by a measure of therapeutic deficiency.
    Anderson JM; Kelly F; Gettinby G; Wood SE
    Cancer; 1977 Jul; 40(1):30-5. PubMed ID: 880558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative depression of tumour-directed cell-mediated immunity in patients with malignant disease.
    Cochran AJ; Spilg WG; Mackie RM; Thomas CE
    Br Med J; 1972 Oct; 4(5832):67-70. PubMed ID: 5077468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular hypersensitivity of gp55 of RIII-murine mammary tumor virus and gp55-like protein of human breast cancers.
    Black MM; Zachrau RE; Dion AS; Shore B; Fine DL; Leis HP; Williams CJ
    Cancer Res; 1976 Nov; 36(11 Pt 1):4137-42. PubMed ID: 184925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro cellular immunity in mammary carcinoma.
    Jones BM; Turnbull AR
    Br J Cancer; 1974 Apr; 29(4):337-9. PubMed ID: 4852381
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.